Clinical Trial Update: A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of tocilizumab alone or with non-biologic antirheumatic drugs in rheumatoid arthritis; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (RoActemra/Actemra) (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-06-19